PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.89%
Revenue growth similar to AVGO's 5.03%. Walter Schloss would see if both companies share industry tailwinds.
5.98%
Gross profit growth similar to AVGO's 6.12%. Walter Schloss would assume both firms track common industry trends.
13.25%
EBIT growth above 1.5x AVGO's 8.76%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
13.25%
Operating income growth above 1.5x AVGO's 8.76%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
17.62%
Net income growth above 1.5x AVGO's 8.21%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
15.87%
EPS growth above 1.5x AVGO's 7.27%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
15.87%
Diluted EPS growth above 1.5x AVGO's 7.41%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.95%
Share count expansion well above AVGO's 0.41%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-0.06%
Reduced diluted shares while AVGO is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
197.99%
Positive OCF growth while AVGO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
249.90%
Positive FCF growth while AVGO is negative. John Neff would see a strong competitive edge in net cash generation.
104.85%
10Y revenue/share CAGR above 1.5x AVGO's 20.57%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
13.16%
5Y revenue/share CAGR at 50-75% of AVGO's 20.57%. Martin Whitman would worry about a lagging mid-term growth trajectory.
6.40%
3Y revenue/share CAGR under 50% of AVGO's 45.14%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
793.32%
10Y OCF/share CAGR above 1.5x AVGO's 86.34%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-26.42%
Negative 5Y OCF/share CAGR while AVGO is at 86.34%. Joel Greenblatt would question the firm’s operational model or cost structure.
409.15%
3Y OCF/share CAGR above 1.5x AVGO's 258.97%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
183.95%
Similar net income/share CAGR to AVGO's 187.85%. Walter Schloss would see parallel tailwinds or expansions for both firms.
45.78%
Below 50% of AVGO's 187.85%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
158.63%
Below 50% of AVGO's 6203.06%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
362.88%
Equity/share CAGR of 362.88% while AVGO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
87.50%
Equity/share CAGR of 87.50% while AVGO is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
43.12%
Below 50% of AVGO's 162.54%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.59%
Firm’s AR is declining while AVGO shows 20.44%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-11.69%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
3.57%
Asset growth at 75-90% of AVGO's 3.98%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
6.68%
1.25-1.5x AVGO's 5.20%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-2.42%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
3.54%
R&D growth drastically higher vs. AVGO's 5.95%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-0.39%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.